First Citizens Bank & Trust’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-76,816
Closed -$800K 668
2025
Q4
$800K Hold
76,816
0.02% 336
2025
Q3
$691K Hold
76,816
0.01% 365
2025
Q2
$999K Hold
76,816
0.02% 284
2025
Q1
$1.94M Hold
76,816
0.05% 189
2024
Q4
$2.64M Hold
76,816
0.05% 155
2024
Q3
$3.8M Hold
76,816
0.08% 132
2024
Q2
$4.62M Hold
76,816
0.09% 110
2024
Q1
$3.96M Buy
+76,816
New +$3.77M 0.08% 126

Other funds holding RXST

First Citizens Bank & Trust's RXST Position: Q1 2026 in Review

First Citizens Bank & Trust sold out of RxSight (RXST) in Q1 2026, closing a stake of 76,816 shares — an estimated $800K sold.

First Citizens Bank & Trust first reported a position in RXST in Q1 2024 and held it in 8 quarters. The position peaked at $4.62M in Q2 2024. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • First Citizens Bank & Trust reported no remaining RxSight position as of Q1 2026 after selling out during the quarter.
  • First Citizens Bank & Trust sold 76,816 RxSight shares in Q1 2026, an estimated $800K.
  • First Citizens Bank & Trust first reported a position in RxSight in Q1 2024 and held it in 8 quarters.
  • First Citizens Bank & Trust's RxSight position peaked at $4.62M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on First Citizens Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.